CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
CHA Comments on Draft Medicare GME Bill
Vaccinate With Confidence
Monthly Vitals: Your Advocacy Update
CHA Comments on Draft Medicare GME Bill
CHA's comments focus on how the bill can be strengthened to better support pediatric training.
Feb. 04, 2025
Vaccinate With Confidence
Access resources and other tools to support vaccination efforts and keep kids healthy.
Feb. 03, 2025
Monthly Vitals: Your Advocacy Update
Learn about Children’s Hospital Association’s latest advocacy efforts and recent legislative impacts for children’s hospitals and health systems.
Jan. 29, 2025
